1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Psychobiotics Market

4. Executive Summary

5. Voice of Customer

5.1. Brand Awareness
5.2. Preferred Mode of Purchase
5.3. Major Factors Contributing to Mental Illness
5.4. Willingness towards Psychobiotics Consumption
5.5. Commonly Observed Psychological Effect Post Consumption

6. Global Psychobiotics Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula)
6.2.2. By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others)
6.2.3. By Form (Powder, Liquid/Fluid, Tablets)
6.2.4. By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online)
6.2.5. By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others)
6.2.6. By Company (2020)
6.2.7. By Region
6.3. Product Market Map

7. North America Psychobiotics Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Psychotropic Agent
7.2.3. By Form
7.2.4. By Distribution Channel
7.2.5. By Application
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Psychobiotics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Psychotropic Agent
7.3.1.2.3. By Form
7.3.1.2.4. By Distribution Channel
7.3.1.2.5. By Application
7.3.2. Mexico Psychobiotics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Psychotropic Agent
7.3.2.2.3. By Form
7.3.2.2.4. By Distribution Channel
7.3.2.2.5. By Application
7.3.3. Canada Psychobiotics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Psychotropic Agent
7.3.3.2.3. By Form
7.3.3.2.4. By Distribution Channel
7.3.3.2.5. By Application

8. Europe Psychobiotics Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Psychotropic Agent
8.2.3. By Form
8.2.4. By Distribution Channel
8.2.5. By Application
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Psychobiotics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Psychotropic Agent
8.3.1.2.3. By Form
8.3.1.2.4. By Distribution Channel
8.3.1.2.5. By Application
8.3.2. Germany Psychobiotics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Psychotropic Agent
8.3.2.2.3. By Form
8.3.2.2.4. By Distribution Channel
8.3.2.2.5. By Application
8.3.3. United Kingdom Psychobiotics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Psychotropic Agent
8.3.3.2.3. By Form
8.3.3.2.4. By Distribution Channel
8.3.3.2.5. By Application
8.3.4. Italy Psychobiotics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Psychotropic Agent
8.3.4.2.3. By Form
8.3.4.2.4. By Distribution Channel
8.3.4.2.5. By Application
8.3.5. Spain Psychobiotics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Psychotropic Agent
8.3.5.2.3. By Form
8.3.5.2.4. By Distribution Channel
8.3.5.2.5. By Application
8.3.6. Sweden Psychobiotics Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Type
8.3.6.2.2. By Psychotropic Agent
8.3.6.2.3. By Form
8.3.6.2.4. By Distribution Channel
8.3.6.2.5. By Application
8.3.7. Poland Psychobiotics Market Outlook
8.3.7.1. Market Size & Forecast
8.3.7.1.1. By Value
8.3.7.2. Market Share & Forecast
8.3.7.2.1. By Type
8.3.7.2.2. By Psychotropic Agent
8.3.7.2.3. By Form
8.3.7.2.4. By Distribution Channel
8.3.7.2.5. By Application
8.3.8. Slovakia Psychobiotics Market Outlook
8.3.8.1. Market Size & Forecast
8.3.8.1.1. By Value
8.3.8.2. Market Share & Forecast
8.3.8.2.1. By Type
8.3.8.2.2. By Psychotropic Agent
8.3.8.2.3. By Form
8.3.8.2.4. By Distribution Channel
8.3.8.2.5. By Application

9. Asia-Pacific Psychobiotics Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Psychotropic Agent
9.2.3. By Form
9.2.4. By Distribution Channel
9.2.5. By Application
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Psychobiotics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Psychotropic Agent
9.3.1.2.3. By Form
9.3.1.2.4. By Distribution Channel
9.3.1.2.5. By Application
9.3.2. India Psychobiotics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Psychotropic Agent
9.3.2.2.3. By Form
9.3.2.2.4. By Distribution Channel
9.3.2.2.5. By Application
9.3.3. South Korea Psychobiotics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Psychotropic Agent
9.3.3.2.3. By Form
9.3.3.2.4. By Distribution Channel
9.3.3.2.5. By Application
9.3.4. Japan Psychobiotics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Psychotropic Agent
9.3.4.2.3. By Form
9.3.4.2.4. By Distribution Channel
9.3.4.2.5. By Application
9.3.5. Australia Psychobiotics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Psychotropic Agent
9.3.5.2.3. By Form
9.3.5.2.4. By Distribution Channel
9.3.5.2.5. By Application
9.3.6. Taiwan Psychobiotics Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Type
9.3.6.2.2. By Psychotropic Agent
9.3.6.2.3. By Form
9.3.6.2.4. By Distribution Channel
9.3.6.2.5. By Application
9.3.7. Malaysia Psychobiotics Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Type
9.3.7.2.2. By Psychotropic Agent
9.3.7.2.3. By Form
9.3.7.2.4. By Distribution Channel
9.3.7.2.5. By Application
9.3.8. Singapore Psychobiotics Market Outlook
9.3.8.1. Market Size & Forecast
9.3.8.1.1. By Value
9.3.8.2. Market Share & Forecast
9.3.8.2.1. By Type
9.3.8.2.2. By Psychotropic Agent
9.3.8.2.3. By Form
9.3.8.2.4. By Distribution Channel
9.3.8.2.5. By Application

10. South America Psychobiotics Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Psychotropic Agent
10.2.3. By Form
10.2.4. By Distribution Channel
10.2.5. By Application
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Psychobiotics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Psychotropic Agent
10.3.1.2.3. By Form
10.3.1.2.4. By Distribution Channel
10.3.1.2.5. By Application
10.3.2. Argentina Psychobiotics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Psychotropic Agent
10.3.2.2.3. By Form
10.3.2.2.4. By Distribution Channel
10.3.2.2.5. By Application
10.3.3. Colombia Psychobiotics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Psychotropic Agent
10.3.3.2.3. By Form
10.3.3.2.4. By Distribution Channel
10.3.3.2.5. By Application

11. Middle East and Africa Psychobiotics Market Outlook

11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Psychotropic Agent
11.2.3. By Form
11.2.4. By Distribution Channel
11.2.5. By Application
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Psychobiotics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Psychotropic Agent
11.3.1.2.3. By Form
11.3.1.2.4. By Distribution Channel
11.3.1.2.5. By Application
11.3.2. Saudi Arabia Psychobiotics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Psychotropic Agent
11.3.2.2.3. By Form
11.3.2.2.4. By Distribution Channel
11.3.2.2.5. By Application
11.3.3. UAE Psychobiotics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Psychotropic Agent
11.3.3.2.3. By Form
11.3.3.2.4. By Distribution Channel
11.3.3.2.5. By Application

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Patent Analysis

16. Competitive Landscape

16.1. Competition Outlook
16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
16.2.1. InnovixLabs
16.2.2. Bened Biomedical Co., Ltd
16.2.3. Nutrimmun GmbH
16.2.4. Kerry Group Plc.
16.2.5. Sabinsa Corporation
16.2.6. Lallemand Health Solutions Inc.
16.2.7. DuPont de Nemours, Inc.
16.2.8. Uplift Food Pty Ltd.
16.2.9. Nature's Bounty Co. Ltd.
16.2.10. BioGaia Group
16.2.11. The Life Extension Foundation
16.2.12. Lifted Naturals

17. Strategic Recommendations

18. About Us & Disclaimer